We report the case of a 77-year-old man who presented with successive aortic aneurysms during a 12-year period. He was first treated in 2006 for an abdominal aortic aneurysm with a bifurcated endograft, then in 2016 for a tender type IV thoracoabdominal aortic aneurysm with a proximal aortic cuff with in situ laser fenestrations. He presented in 2018 with a 9-cm distal thoracic aorta aneurysm managed by an off-the-shelf t-Branch endograft (Cook Medical, Bloomington, Ind). The perioperative course was uneventful, and 6-month follow-up computed tomography scan has shown freedom from endoleaks and branch patency. This case illustrates that apparently "healthy" aortic necks can degenerate after endovascular aneurysm repair. (J Vasc Surg Cases and Innovative Techniques 2019;5:544-8.) 
Proximal aortic neck dilation after endovascular aneurysm repair (EVAR) and open aortic surgical repair has been widely reported. [1] [2] [3] [4] [5] [6] Subsequent interventions can be challenging, especially in emergency presentations, such as tender, ruptured, or very large aneurysms. [7] [8] [9] Open conversion can be considered in fit patients, but off-label use of available endovascular grafts may be the only realistic treatment option.
CASE REPORT
We report the case of a 77-year-old man with a history of recurrent degeneration of apparently adequate aortic sealing zones after initially successful infrarenal EVAR. Consent to publish was obtained from the patient. His past medical history included granulomatosis with polyangiitis, hypertension, atrial fibrillation, and a nonspecific polyarthritis. The patient was never genetically tested.
The patient was first treated for a 58-mm-diameter abdominal aortic aneurysm (AAA) in 2006 (at the age of 65 years) with a standard bifurcated 34-mm Talent endograft (Medtronic Vascular, Santa Rosa, Calif). At that time, the infrarenal aortic neck was 20 mm long and 28 mm in diameter. Annual computed tomography (CT) follow-up from 2006 to 2014 showed an excluded aneurysm with stable aortic and neck diameters. In 2016, a proximal type IA endoleak secondary to aneurysmal degeneration of the visceral aorta ( Fig 1) was found.
The maximum diameter of the aneurysm had increased to 89 mm, and it was clinically tender. This was treated urgently using a proximal aortic cuff (Endurant II 36-49; Medtronic), positioned with one proximal sealing stent above the celiac trunk to provide aortic sealing and AAA exclusion. In situ laser fenestrations of the proximal cuff were created to allow the placement of covered, balloon-expandable bridging stents to both renal arteries, the superior mesenteric artery, and the celiac trunk (Advanta V12;
Maquet Getinge Group, Rastatt, Germany). It provided a 25-mmlong seal in a 31-mm-diameter visceral aorta. This solution was preferred to a custom-made fenestrated endograft because of the aneurysm diameter, aortic tenderness, and risk of rupture inherent in the manufacturing delay for the custom-made device at that time. The postoperative 1-month and 1-year CT scans showed no endoleak and patent visceral vessels ( Fig 2) .
He did not show up to his follow-up visits. Two years later, in 2018, he presented with a symptomatic 90-mm aneurysm of the distal thoracic aorta (DTA), above the previous repair, and an occlusion of the left renal artery bridging stent (Fig 3) .
This new thoracic aortic aneurysm was excluded using an off-the-shelf t-Branch endograft (Cook Medical, Bloomington, Ind). We employed our standard treatment strategies including cerebrospinal fluid drainage. In addition, we elected to precatheterize the three patent target vessels through a femoral approach to position "buddy wires" and also to preflare the aortic portions of the existing bridging stents using 12-Â 20-mm balloons. The t-Branch device was deployed from the contralateral groin, and the right renal artery, the superior mesenteric artery, and the celiac stents and vessels were cathe- (Fig 4) . The proximal sealing zone is currently 35 mm long. The aortic diameter at that level is 33 mm. Before and after the third procedure, no graft or aortic infection was suspected on CT scan, and no fever or C-reactive protein or white blood cell elevation was observed.
DISCUSSION
This case report illustrates the importance of always anticipating the next step in performing EVAR (planning for manageable failure). Aortas that contain aneurysms in one segment are not truly "healthy," and further aneurysmal degeneration affecting both sealing zones and previously uninvolved segments over time is not rare. It is therefore important to plan sealing zones compatible with future EVAR extensions, most particularly in young first-time presenters with long predicted remaining life spans. After 8 years of uneventful follow-up, our patient experienced rapid aneurysm growth and was exposed to rupture, underlining the importance of lifelong imaging follow-up after EVAR. Extended follow-up is difficult to achieve, however. 10, 11 Arterial aneurysms are a rare complication of granulomatosis with polyangiitis. 12 Our patient had regular follow-up of his disease that was controlled with prednisolone treatment. The unexpected development of his thoracic aneurysm could be linked to this underlaying pathologic process.
Oberhuber et al 1 reported a mean neck enlargement of 2 mm after a mean follow-up of 34 months following both endovascular and open surgical treatment of AAA. Monahan et al 3 documented a mean 5.3-mm dilation at 48-month follow-up after EVAR in their cohort in which neck enlargement was observed in all patients during follow-up. Rodway et al 2 described a greater rate of neck enlargement after endovascular repair than after open surgical repair. Furthermore, whereas neck enlargement is reported to be most rapid between 24 and 36 months after EVAR, it does not stop after 5 years of follow-up. 4 Finally, the literature suggests that neck enlargement is independent of sac regression and reinterventions 5 but may be related to endograft oversizing. 6 Failing EVAR with proximal type I endoleaks is not infrequent when the neck diameter is $28 mm, as shown in this case report. 13 The endoleaks are most likely to be resealed by proximal fenestrated or branched cuffs. 7 These reinterventions are more challenging than similar operations in previously untreated aortas 8 but are nonetheless possible and generally successful in experienced hands. An alternative therapeutic option is reversion to open surgical repair with explantation of the endograft, but this is a considerable undertaking and physiologic challenge. It is the firstline option in fit patients but is associated with appreciable procedure-related risks. 9 In circumstances of urgency (symptomatic or very large aneurysms), treatment options include chimney EVAR, 14 in situ laser fenestrations, 15 physician-modified endografts, 16 and use of off-the-shelf endografts such as the t-Branch endograft. 17 In this case report, the failing EVAR was treated with an in situ laser fenestrated EVAR (FEVAR). The failing FEVAR was subsequently relined using a multibranched endograft. Had the previous FEVAR been performed with two or more sealing stents above the celiac fenestration, the later DTA aneurysm would have been easily excluded by simply relining the FEVAR with a standard thoracic endovascular aortic repair proximal extension. Precatheterization of the target vessels and flaring of the bridging stents secured access by preventing irretrievable crushing of the original bridging stents and facilitated implantation of the new bridging stents. We have found the routine use of steerable sheaths in such complex procedures a very helpful adjunct.
CONCLUSIONS
Thoracoabdominal multibranched endografts can be inserted through failed FEVAR devices when proximal seal fails. Better planning of the original FEVAR cuff with two or more proximal sealing stents above the highest fenestration would have greatly simplified the management of the DTA.
